ZEPP — Stock Film
STOCK FILMSCENE 1/11ZEPP · $5.44
Stock Expert AI presents
ZEPP
Zepp Health Corporation
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Zepp Health Corporation. A quick introduction.

On the stock market since 2018, it operates in the world of technology. It has 763 employees. Now — the numbers.

on the stock market since 2018
763 employees
$77.9M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.2.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
74%Manufactured Product, Other
Manufactured Product, Other 74%Products 26%
74% of all revenue comes from a single line: Manufactured Product, Other.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are growing overall, with a pause along the way.

Average growth of 17% a year over the last 4 years. Red columns mark years that ended in a loss.

$968.7M
2021
$615.7M
2022
$352.6M
2023
$1.3B
2024
$1.8B
2025
In the vault right now:
$0
DEBT: $1.6B
At this pace, that money lasts about 2.8 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark0/10
THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 91% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 43% a year on average.

2
THE BRIGHT SIDE · 2/3
Sales are holding up

The company sells $1.8B a year; the problem isn’t sales — it’s costs running above that number.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $12.00121% above today’s price.

1
THE RISKS · 1/2
The losses continue

A loss of $280.9M against $1.8B in annual sales.

2
THE RISKS · 2/2
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, ZEPP sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: ZEPP has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 24, 2026 · stockexpertai.com · Stock Film